John Tat

Dr. John Tat

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2026 in Toxics
Verified
Journal Article
Open access
PDF file
CSConnor Bradley Stauffer
Connor Bradley Stauffer
JTJohn Tat
John Tat
Sulfur dioxide (SO2) is a colorless, pungent gas that is a significant contributor to air pollution, with well-documented environmental and health impacts. It is emitted both naturally (e.g., in volcanic activities) and anthropogenically (e.g., fossil fuel combustion, sulfuric acid production, papermaking, and wine preservation). Inhalation represents the primary route of human exposure, particularly in urban and industrial settings. Acute SO2 exposure can lead to airway irritation, laryngospasm, bronchoconstriction, pulmonary edema, and death in severe cases. Chronic exposure, even at low concentrations, can contribute to the development of pulmonary and extrapulmonary diseases. Despite its classification as a hazardous air pollutant, a comprehensive understanding of dose-response relationships, exposure thresholds, and mechanisms of toxicity for SO2 remains limited. This review synthesizes current knowledge on environmental sources, exposure routes, mechanisms of toxicity, and health impacts of SO2, highlighting findings from epidemiological, toxicological, and mechanistic studies. We also discuss gaps in knowledge regarding SO2, approaches to monitor and assess SO2 exposure in ambient environments, the emerging role of SO2 as a gasotransmitter, and areas where further research is needed to better understand health risks and support evidence-based public health decision-making.

15 May 2026 in Toxics
Verified
Journal Article
Open access
PDF file
AKAnirudh Kalyanaraman
Anirudh Kalyanaraman
CSConnor Bradley Stauffer
Connor Bradley Stauffer
WGWeirui Gao
Weirui Gao
TZTong Zhong
Tong Zhong
ANAlexandra Quyen Thuy Nguyen
Alexandra Quyen Thuy Nguyen
JTJohn Tat
John Tat
Polycyclic aromatic hydrocarbons (PAHs) are common environmental contaminants formed during the incomplete combustion of organic material. Their persistence, bioaccumulation, and metabolic activation contribute to mutagenic and cytotoxic outcomes. Among these are benzo[a]pyrene (B[a]P), the most studied PAH and a benchmark compound for PAH carcinogenicity, and pyrene, a PAH whose urinary metabolite 1-hydroxypyrene is widely used as a biomarker of PAH exposure. B[a]P undergoes CYP1A1-mediated oxidation to generate reactive oxygen species (ROS) via epoxide and quinone redox cycling, whereas pyrene produces ROS primarily through pyrene-quinone redox cycling. We investigated cobinamide, a vitamin B12/cobalamin analog with potent antioxidant properties, for mitigating benzo[a]pyrene- and pyrene-induced injury. In H9C2 rat embryonic cardiomyoblasts and A549 human lung epithelial cells exposed to B[a]P (10 μM) or pyrene (10–100 μM), cobinamide (5–10 μM) attenuated PAH-induced reductions in cell number in both models, while in H9C2 cells, it also attenuated decreases in metabolic activity and reduced apoptosis. Cobinamide also returned JNK/p38 phosphorylation to near baseline levels, decreased DNA and protein oxidation and DNA strand breaks. Transcriptionally, cobinamide suppressed inflammatory (TNF-α, IL-1β, and IL-6) and oxidative stress genes (HMOX1 and NOX4), while enhancing oxidative response (SOD2) and xenobiotic metabolism (CYP1A1). In Drosophila melanogaster exposed to 5 mM B[a]P/pyrene, 2 mM cobinamide improved survival and fully restored locomotion, outperforming cobalamin (minimal benefit) and N-acetylcysteine (partial rescue). Spectroscopic analyses showed no direct cobinamide-PAH binding. These findings demonstrate that cobinamide efficiently limits ROS-mediated PAH injury through redox modulation while preserving xenobiotic metabolism, suggesting its potential therapeutic use to mitigate PAH-induced toxicity.